Skip to content
BOE-A-2026-15350 ·14 July 2026 ·Resolution not-relevant
Administrative

Central Government and Regional Health Services: minor procurement must be limited to 30% of hospital pharmaceutical expenditure by 2027

The Joint Commission for Relations with the Court of Auditors urges the Government and the Health Services of Cantabria, Extremadura, Murcia, and La Rioja to rectify deficiencies in the management of hospital pharmaceutical expenditure (2022 financial year). The resolution requires that minor procurement be limited to 30% of pharmaceutical expenditure in these regions by 2027, while improving transparency and inventory control (point 1). Additionally, it calls for the creation of a National Health System Board to harmonise medicine prices across autonomous communities.

In 3 key points

  1. Minor procurement limited to 30% of hospital pharmaceutical expenditure by 2027, point 1 (punto 1)
  2. Publication of quarterly execution reports on the Procurement Platform within 6 months, point 1 (punto 1)
  3. Coverage of over 80% of high-value stock with approved manuals within 60 days, point 1 (punto 1)

Lifecycle

2026-07-14PublishedPublished in the BOE
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The administrative team reviews your specific situation.

Talk to the administrative team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact